Omeros Corporation
Biopharmaceutical company focused on small-molecule and protein therapeutics.
Based in WA
🤖
AI Overview
With $765K in lobbying spend across 21 quarterly filings, Omeros Corporation is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2025.
$765K
Total Spend
6
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $45K |
| 2021 | $135K |
| 2022 | $180K |
| 2023 | $180K |
| 2024 | $180K |
| 2025 | $45K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid
- •Issues related to medicare reimbursement.
- •Reimbursement classification of OMIDRIA.
- •Monitor Medicare reimbursement for ophthalmic drugs under the Hospital Outpatient Prospective Payment System and Ambu
- •Issues related to Medicare reimbursement.
- •Reimbursement classification of OMIDRIA. Monitor Medicare reimbursement for ophthalmic drugs under the Hospital Outpatient Prospective Payment System and Amb
- •Issues related to Medicare reimbursement.
- •Reimbursement classification of OMIDRIA. Monitor Medicare reimbursement for ophthalmic drugs under the Hospital Outpatient Prospective Payment System and Ambu
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.